Skip to main content

previous disabled Page of 3
and
  1. Article

    Diagnosing sepsis: where we’re at and where we’re going

    Tobias Zimmermann, David Brealey, Mervyn Singer in Intensive Care Medicine (2024)

  2. Article

    2030: The need for microbiologists and antimicrobial stewardship teams will still remain paramount. Author’s reply

    Ines Lakbar, Mervyn Singer, Marc Leone in Intensive Care Medicine (2023)

  3. Article

    2030: will we still need our microbiologist?

    Ines Lakbar, Mervyn Singer, Marc Leone in Intensive Care Medicine (2023)

  4. Article

    Trials on oxygen targets in the critically ill patients: do they change our knowledge and practice?

    Massimo Girardis, Angelique M. E. de Man, Mervyn Singer in Intensive Care Medicine (2023)

  5. Article

    How to use biomarkers of infection or sepsis at the bedside: guide to clinicians

    Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection. In this context, biomarkers could be considered as indicators of either infection or dysregulated ...

    Pedro Póvoa, Luís Coelho, Felipe Dal-Pizzol, Ricard Ferrer in Intensive Care Medicine (2023)

  6. No Access

    Article

    Management of diabetic ketoacidosis

    Bruno A. M. P. Besen, Otavio T. Ranzani, Mervyn Singer in Intensive Care Medicine (2023)

  7. Article

    Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity

    Puja Mehta, Ivan O. Rosas, Mervyn Singer in Intensive Care Medicine (2022)

  8. Article

    High oxygen level in traumatic brain injury patients. Never ending story?

    Karim Asehnoune, Fabio S. Taccone, Mervyn Singer in Intensive Care Medicine (2022)

  9. Article

    Presymptomatic diagnosis of postoperative infection and sepsis using gene expression signatures

    Early accurate diagnosis of infection ± organ dysfunction (sepsis) remains a major challenge in clinical practice. Utilizing effective biomarkers to identify infection and impending organ dysfunction before th...

    Roman A. Lukaszewski, Helen E. Jones, Vivian H. Gersuk in Intensive Care Medicine (2022)

  10. Article

    The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's reply

    Daniel A. Hofmaenner, Mervyn Singer in Intensive Care Medicine (2022)

  11. Article

    Challenging management dogma where evidence is non-existent, weak or outdated

    Medical practice is dogged by dogma. A conclusive evidence base is lacking for many aspects of patient management. Clinicians, therefore, rely upon engrained treatment strategies as the dogma seems to work, or...

    Daniel A. Hofmaenner, Mervyn Singer in Intensive Care Medicine (2022)

  12. Article

    “L'histoire se répète”, one size does not fit all. Author’s reply

    Timothy Arthur Chandos Snow, Naveed Saleem, Mervyn Singer in Intensive Care Medicine (2021)

  13. Article

    Do not just sit there, do something … but do no harm: the worrying aspects of COVID-19 experimental interventions

    Mervyn Singer, Andre Kalil in Intensive Care Medicine (2021)

  14. Article

    Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials

    Interleukin-6 (IL-6) levels discriminate between patients with mild and severe COVID-19, making IL-6 inhibition an attractive therapeutic strategy. We conducted a systematic review, meta-analysis, trial sequen...

    Timothy Arthur Chandos Snow, Naveed Saleem, Gareth Ambler in Intensive Care Medicine (2021)

  15. Article

    Steroids in ARDS: more light is being shed

    Nishkantha Arulkumaran, Timothy Arthur Chandos Snow in Intensive Care Medicine (2020)

  16. Article

    Do critical care patients hibernate? Theoretical support for less is more

    Giacomo Stanzani, Robert Tidswell, Mervyn Singer in Intensive Care Medicine (2020)

  17. No Access

    Article

    Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trial

    Myocardial dysfunction is common in sepsis but optimal treatment strategies are unclear. The inodilator, levosimendan was suggested as a possible therapy; however, the levosimendan to prevent acute organ dysfu...

    David B. Antcliffe, Shalini Santhakumaran, Robert M. L. Orme in Intensive Care Medicine (2019)

  18. Article

    Open Access

    Correction to: Impact on mortality of prompt admission to critical care for deteriorating ward patients: an instrumental variable analysis using critical care bed strain

    This article was originally published under a CC BY-NC 4.0 license, but has now been made available under a CC BY 4.0 license. The PDF and HTML versions of the paper have been modified accordingly.

    Steve Harris, Mervyn Singer, Colin Sanderson, Richard Grieve in Intensive Care Medicine (2018)

  19. Article

    Open Access

    Impact on mortality of prompt admission to critical care for deteriorating ward patients: an instrumental variable analysis using critical care bed strain

    To estimate the effect of prompt admission to critical care on mortality for deteriorating ward patients.

    Steve Harris, Mervyn Singer, Colin Sanderson, Richard Grieve in Intensive Care Medicine (2018)

  20. Article

    Open Access

    Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)

    The CIGMA study investigated a novel human polyclonal antibody preparation (trimodulin) containing ~ 23% immunoglobulin (Ig) M, ~ 21% IgA, and ~ 56% IgG as add-on therapy for patients with severe community-acq...

    Tobias Welte, R. Phillip Dellinger, Henning Ebelt, Miguel Ferrer in Intensive Care Medicine (2018)

previous disabled Page of 3